Project Details
Description
PROJECT SUMMARY/ABSTRACT
This proposal will improve the care of patients suffering from Acute Ischemic stroke (AIS). Catheter-based
thrombectomy has been established as the standard treatment for AIS. Still, substantial limitations remain: 30% over conventional DACs), but struggle with navigation challenges in
tortuous anatomies, with nearly half of procedures resulting in failure to navigate to the clot face. While they
provide a major advance in DAC sizing, SuperBores have not been considered for TRA approaches due to
their thick walls and stiff tips, precluding the ability to achieve optimized navigation or suction power from the
radial approach. Our team discovered this pressing need after achieving acquisition by Medtronic of our
previous SBIR-funded program via intensive interviews of 50+ physicians.
In our successful Phase I project, we developed and tested our novel SuperBore thrombectomy system
appropriate for TRA. Specifically, our “Wrist-to-Brain” thrombectomy system provides the distinct advantages
of: (1) combining guide catheter and SuperBore DAC in a single catheter, (2) hyperthin walls enabled by our
novel, proprietary liner, and (3) a highly trackable and kink resistant shaft that still fits within the radial artery in
most patients. In this Phase II SBIR program, we propose a full, formal validation program guided by FDA
testing criteria (Aim 1), followed by extensive benchtop, GLP animal, and cadaveric testing (Aim 2). This grant
will enable us to complete all testing needed to submit for FDA clearance and begin marketing our novel and
impactful Wrist-to-Brain thrombectomy system in order to improve the care of patients suffering from LVO AIS.
Status | Active |
---|---|
Effective start/end date | 9/29/23 → 6/30/24 |
Funding
- National Institute of Neurological Disorders and Stroke: $992,721.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.